Background Epstein-Barr virus (EBV) is strongly implicated in the development of multiple sclerosis (MS) but whether ...

Background The effectiveness of disease-modifying therapies (DMTs) in multiple sclerosis (MS) declines with age, while ...

Correspondence to Dr A J Larner, Cognitive Function Clinic, Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool L9 7LJ, UK; a.larner{at}thewaltoncentre.nhs.uk While taking the history ...

Correspondence to Dr Brigid Ryan, Department of Anatomy and Medical Imaging, The University of Auckland, Auckland 1142, New Zealand; b.ryan{at}auckland.ac.nz Introduction Young-onset dementia ...

aDepartment of Ophthalmology, University of Alabama School of Medicine, 601 700 South 18th Street, Birmingham, Alabama, USA, bNeuro-ophthalmology Unit, University of California School of Medicine, San ...

Department of Medicine, Wellington School of Medicine and Health Sciences, University of Otago, Wellington, New Zealand Correspondence to: R J Siegert Rehabilitation Teaching and Research Unit, ...

Objective To report the clinical and immunological characteristics of 22 new patients with glial fibrillar acidic protein (GFAP) autoantibodies. Methods From January 2012 to March 2017, we recruited ...

Background Air pollution has been proposed as a short-term trigger of multiple sclerosis (MS) relapses, but delayed effects ...

Polyneuropathy, Organomegaly, Endocrinopathy, M-protein and Skin changes (POEMS) syndrome is a rare multisystemic disorder associated with plasma cell dyscrasia, most commonly presenting with ...

Background We report our experience of patients with generalised myasthenia gravis (gMG) treated with efgartigimod, an neonatal Fc receptor antagonist, under the Early Access to Medicine Scheme (EAMS) ...

Background and purpose Current guidelines recommend endovascular treatment (EVT) for acute ischaemic stroke (AIS), due to large-vessel occlusion and an Alberta Stroke Program Early CT Score (ASPECTS) ...

Objectives Recently, IgG autoantibodies against different paranodal proteins have been detected and this has led to important advances in the management of inflammatory neuropathies. In contrast, not ...